EPA0020 | Heavily Treatment-Experienced (HTE) people living with HIV (PLWH) with vertical transmission and detectable viremia do not display increased peripheral inflammation markers: data from the Prestigio Registry | E-poster | HIV pathogenesis |
EPA0021 | Urethral microbiome of South African cis-gender men and transwomen with and without bacterial sexually transmitted infections | E-poster | HIV pathogenesis |
EPA0022 | Microbial dysbiosis is associated with peripheral inflammation in vertically infected youth with HIV on stable anti-retroviral therapy | E-poster | HIV pathogenesis |
EPA0023 | Massive HIV infection abrogates osteoclastogenesis by influencing CCR5 and CD9 expression | E-poster | HIV pathogenesis |
EPA0024 | Impact of the synthetic opioid fentanyl on HIV replication in vitro | E-poster | HIV pathogenesis |
EPA0025 | Role of transcriptionally-active "defective" HIV-1 proviruses in immunological non-responders: a case-control study | E-poster | HIV pathogenesis |
EPA0026 | Frequencies of CD4+ and CD8+ T cells immune activation are reduced in PLWH after 5 years of antiretroviral therapy | E-poster | HIV pathogenesis |
EPA0027 | miRNAs regulated by reproductive hormones and pregnancy target the HIV interactome | E-poster | HIV pathogenesis |
EPA0028 | Identification of SIV infected mast cells in early sites of viral rebound | E-poster | HIV pathogenesis |
EPA0029 | Early initiation of anti-retroviral therapy restores some but not all perturbations of natural killer cell functions and phenotypes in early HIV-1 infected men who have sex with men | E-poster | Host immune responses, vaccines and immunotherapies |